Patent Assignment
Reel/Frame 075494/0756
Assignment of Assignor's Interest
Recorded: 2026-04-28
Pages: 10
Assignor
THERAVANCE BIOPHARMA R&D IP, LLC
Executed: 2025-07-30
Assignee
EONHF, INC.
NEW YORK TIMES BUILDING, 620 EIGHTH AVE., NEW YORK, NEW YORK, 10018
Covered Properties
(45)
Process for Preparing 4-Amino-5-Biphenyl-4-Yl-2-Hydroxymethyl-2-Methyl-Pentanoic Acid Compounds
Process for Preparing 4-Amino-5-Biphenyl-4-Yl-2-Hydroxymethyl-2-Methyl-Pentanoic Acid Compound
Process for Preparing 4-Amino-5-Biphenyl-4-Yl-2-Hydroxymethyl-2-Methyl-Pentanoic Acid Compound
Process for Preparing 4-Amino-5-Biphenyl-4-Yl-2-Hydroxymethyl-2-Methyl-Pentanoic Acid Compound
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Crystalline(2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Bipheny]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-Yl)-2-(Ethoxymethyl)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
Neprilysin Inhibitors
(2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)Amino]Pentanoic Acid
(2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)Amino]Pentanoic Acid
(2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)Amino]Pentanoic Acid
(2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)Amino]Pentanoic Acid
(2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)Amino]Pentanoic Acid
(2S,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-4-(Ethoxyoxalylamino)-2-Hydroxymethyl-2-Methylpentanoic Acid
(2S,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-4-(Ethoxyoxalylamino)-2-Hydroxymethyl-2-Methylpentanoic Acid
(2S,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-Yl)-4-(Ethoxyoxalylamino)-2-Hydroxymethyl-2-Methylpentanoic Acid
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 14, 2013
From: RAPTA, MIROSLAV
To: THERAVANCE, INC.
Reel/Frame 029816/0095 →
Assignment of Assignor's Interest
Aug 7, 2013
From: FLEURY, MELISSA; HUGHES, ADAM D.
To: THERAVANCE, INC.
Reel/Frame 030962/0247 →
Assignment of Assignor's Interest
Jun 3, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033125/0044 →
Assignment of Assignor's Interest
Jun 5, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033127/0411 →
Assignment of Assignor's Interest
Jun 19, 2017
From: HUGHES, ADAM D.; FLEURY, MELISSA; RAPTA, MIROSLAV; THALLADI, VENKAT R.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 042750/0708 →